Strategic Advocates »

Editas Medicine shares owned by Strategic Advocates

Quarter-by-quarter ownership of Editas Medicine (EDIT) shares owned by Strategic Advocates from 13F filings

Historical chart of Strategic Advocates investment in Editas Medicine

Tip: Access up to 7 years of quarterly data

All positions including Editas Medicine held by Strategic Advocates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Editas Medicine by Strategic Advocates

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.7k 1.1k 3.47

More positions owned by Strategic Advocates

State Street Spdr S&p Kensho New Economies Composite Etf Etf (KOMP)
Invesco Qqq Trust Series I Etf (QQQ)
Vanguard Intermediate-term Bond Etf Etf (BIV)
Invesco S&p 500 Pure Value Etf Etf (RPV)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
State Street Spdr Portfolio Long Term Corporate Bond Etf Etf (SPLB)
Vanguard S&p Small-cap 600 Growth Etf Etf (VIOG)
Ishares 1-5 Year Investment Grade Corporate Bond Etf Etf (IGSB)
Nvidia Corporation Stock (NVDA)
Apple Stock (AAPL)
Palantir Technologies Inc Cl A Stock (PLTR)
Tesla Stock (TSLA)
Pimco 0-5 Year High Yield Corporate Bond Index Exchange-traded Fund Etf (HYS)
Amazon Stock (AMZN)
Meta Platforms Inc Cl A Stock (META)

View all positions for Strategic Advocates

Top funds holding Editas Medicine

BlackRock
Vanguard Group
Nuveen
Geode Capital Management
State Street Corporation
Two Sigma Investments
Morgan Stanley
Renaissance Technologies
Two Sigma Advisers
Susquehanna International
Dimensional Fund Advisors
Jpmorgan Chase & Co
Jacobs Levy Equity Management
Charles Schwab Investment Management
AQR Capital Management

View all funds holding Editas Medicine